| # | Drug | Count |
|---|---|---|
| 0 | OMEPRAZOLE MAGNESIUM | 534 |
| 1 | OMEPRAZOLE | 501 |
| 2 | LEVOTHYROXINE SODIUM | 477 |
| 3 | LANSOPRAZOLE | 474 |
| 4 | SIMVASTATIN | 469 |
| 5 | ESOMEPRAZOLE MAGNESIUM | 466 |
| 6 | NAPROXEN SODIUM | 458 |
| 7 | APIXABAN | 454 |
| 8 | CETIRIZINE HYDROCHLORIDE | 454 |
| 9 | HYDROCHLOROTHIAZIDE | 440 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ESTRIOL | 368 | 0.2008 |
| 1 | FELODIPINE | 399 | 0.0349 |
| 2 | AMITRIPTYLINE HYDROCHLORIDE | 384 | 0.0213 |
| 3 | LINAGLIPTIN | 392 | 0.0212 |
| 4 | ISOSORBIDE DINITRATE | 372 | 0.0190 |
| 5 | ISOSORBIDE MONONITRATE | 385 | 0.0184 |
| 6 | SENNOSIDES A AND B | 26 | 0.0158 |
| 7 | MINERAL OIL | 23 | 0.0155 |
| 8 | CETIRIZINE HYDROCHLORIDE TABLETS | 272 | 0.0087 |
| 9 | CANDESARTAN | 289 | 0.0080 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 876 |
| 1 | Proton Pump Inhibitor [EPC] | 632 |
| 2 | HMG-CoA Reductase Inhibitor [EPC] | 542 |
| 3 | Factor Xa Inhibitor [EPC] | 495 |
| 4 | Dihydropyridine Calcium Channel Blocker [EPC] | 487 |
| 5 | Thiazide Diuretic [EPC] | 467 |
| 6 | Nitrate Vasodilator [EPC] | 428 |
| 7 | Cardiac Glycoside [EPC] | 406 |
| 8 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 402 |
| 9 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 394 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 9 | 0.0131 |
| 1 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 394 | 0.0121 |
| 2 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 42 | 0.0060 |
| 3 | Provitamin D2 Compound [EPC] | 170 | 0.0057 |
| 4 | Cardiac Glycoside [EPC] | 406 | 0.0056 |
| 5 | Nitrate Vasodilator [EPC] | 428 | 0.0048 |
| 6 | CD4-directed Blocking Antibody [EPC] | 2 | 0.0037 |
| 7 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 402 | 0.0037 |
| 8 | Nucleoside Analog Antifungal [EPC] | 5 | 0.0035 |
| 9 | Guanylate Cyclase-C Agonist [EPC] | 7 | 0.0034 |